A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

作者：Alexander C. Huang, Robert Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M. George, Patrick Yan, Sasikanth Manne, Adam Kraya, Bradley Wubbenhorst, Liza M. Dorfman, Kurt D’Andrea, Brandon M. Wenz, Shujing Liu, Lakshmi Chilukuri, Andrew Kozlov, Mary Carberry, Lydia Giles, Melanie Wain Kier, Felix Quagliarello, Suzanne McGettigan, Kristin Kreider, Lakshmanan Annamalai, Qing Zhao, Robin Mogg, Wei Xu, Wendy M. Blumenschein, Jennifer H. Yearley, Gerald P. Linette, Ravi K. Amaravadi, Lynn M. Schuchter, Ramin S. Herati, Bertram Bengsch, Katherine L. Nathanson, Michael D. Farwell, Giorgos C. Karakousis, E. John Wherry, Tara C. Mitchell · 发表于：Nature Medicine · 年份：2019 · DOI：10.1038/s41591-019-0357-y · 被引用次数：714 · 研究领域：Cancer Immunotherapy and Biomarkers、Immunotherapy and Immune Responses、CAR-T cell therapy research